Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 19/20 | 0.43 |
| ▸ | PPARA | Q07869 | 19/20 | 0.43 |
| ▸ | PPARD | Q03181 | 13/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4329073 | 0.91 | FFAR1 (0.37) | PPARGPPARAPPARDFFAR1 | |
| SCHEMBL4335943 | 0.83 | FFAR1 (0.35) | PPARGPPARAFFAR1 | |
| SCHEMBL4334556 | 0.82 | PPARA (0.46) | PPARGPPARAPPARD | |
| SCHEMBL4333221 | 0.80 | CYP11B1 (0.43) | PPARGPPARAPPARD | |
| SCHEMBL4335811 | 0.80 | PPARD (0.44) | PPARGPPARAPPARD | |
| SCHEMBL4348570 | 0.78 | PPARA (0.51) | PPARGPPARAPPARDFFAR1 | |
| SCHEMBL4346174 | 0.78 | GPR34 (0.45) | PPARGPPARAPPARDFFAR1 | |
| SCHEMBL4337033 | 0.78 | PPARA (0.58) | PPARGPPARAPPARD | |
| SCHEMBL6650894 | 0.78 | ALDH1A1 (0.47) | PPARGPPARAPPARD | |
| SCHEMBL4335069 | 0.77 | PPARA (0.48) | PPARGPPARAPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7544835-B2 | Carboxylic acid derivative and salt thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2009-06-09 | — | — | US | disclosed |
| US-7544835-B2 | Carboxylic acid derivative and salt thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2009-06-09 | — | — | US | disclosed |
| US-7544835-B2 | Carboxylic acid derivative and salt thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2009-06-09 | — | — | US | disclosed |
| US-20040102634-A1 | Carboxylic acid derivative and salt thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2004-05-27 | — | — | US | disclosed |
| EP-1380562-A1 | CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF | Eisai Co., Ltd. (JP) | 2004-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102634-A1 | Carboxylic acid derivative and salt thereof | GPR119, IRS1, SLC5A1 | PPARG 379/4885PPARA 339/4885PPARD 753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.